Avidity Biosciences (RNA) News Today $46.35 +1.69 (+3.78%) Closing price 08/22/2025 04:00 PM EasternExtended Trading$46.45 +0.10 (+0.22%) As of 08/22/2025 07:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock RNA Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Avidity Biosciences (NASDAQ:RNA) Insider Sells $102,451.20 in StockAugust 23 at 9:18 AM | insidertrades.comCandriam S.C.A. Increases Stock Position in Avidity Biosciences, Inc. $RNAAugust 23 at 7:07 AM | marketbeat.comWellington Management Group LLP Has $285.89 Million Stock Holdings in Avidity Biosciences, Inc. $RNAAugust 22 at 5:05 AM | marketbeat.comAberdeen Group plc Increases Holdings in Avidity Biosciences, Inc. $RNAAugust 22 at 4:18 AM | marketbeat.comAvidity Biosciences, Inc. $RNA Shares Sold by Swiss National BankAugust 22 at 3:29 AM | marketbeat.comAvidity Biosciences Sees Unusually High Options Volume (NASDAQ:RNA)August 21 at 7:12 PM | marketbeat.comAvidity Biosciences (NASDAQ:RNA) Trading Down 4.2% on Insider SellingAugust 20 at 3:46 PM | marketbeat.comAvidity Biosciences, Inc. (NASDAQ:RNA) Receives $67.00 Consensus PT from AnalystsAugust 20 at 3:01 AM | americanbankingnews.comAvidity Biosciences (NASDAQ:RNA) Stock Price Down 4.2% on Insider SellingAugust 20 at 2:35 AM | americanbankingnews.comAvidity Biosciences, Inc. $RNA Holdings Cut by Vanguard Group Inc.August 19, 2025 | marketbeat.comAvidity Biosciences, Inc. (NASDAQ:RNA) Shares Purchased by Citigroup Inc.August 18, 2025 | marketbeat.comAvidity Biosciences, Inc. (NASDAQ:RNA) Shares Sold by Deutsche Bank AGAugust 18, 2025 | marketbeat.comAvidity Biosciences, Inc. (NASDAQ:RNA) Insider Sells $465,600.00 in StockAugust 17, 2025 | marketbeat.comTeresa Mccarthy Sells 10,000 Shares of Avidity Biosciences, Inc. (NASDAQ:RNA) StockAugust 16, 2025 | insidertrades.comAvidity Biosciences, Inc. (NASDAQ:RNA) Given Consensus Recommendation of "Buy" by AnalystsAugust 16, 2025 | marketbeat.comAvidity Biosciences (NASDAQ:RNA) Shares Gap Down on Insider SellingAugust 12, 2025 | marketbeat.comWhat is Leerink Partnrs' Estimate for RNA FY2027 Earnings?August 12, 2025 | marketbeat.comMackenzie Financial Corp Invests $213,000 in Avidity Biosciences, Inc. (NASDAQ:RNA)August 11, 2025 | marketbeat.comTroy Edward Wilson Sells 65,554 Shares of Avidity Biosciences, Inc. (NASDAQ:RNA) StockAugust 10, 2025 | marketbeat.comAvidity Biosciences, Inc. (NASDAQ:RNA) Insider Steven George Hughes Sells 81,434 SharesAugust 10, 2025 | marketbeat.comAvidity Biosciences, Inc. (NASDAQ:RNA) Director Sells $5,119,150.00 in StockAugust 10, 2025 | marketbeat.comAvidity Biosciences, Inc. (NASDAQ:RNA) Insider Eric Mosbrooker Sells 130,807 SharesAugust 10, 2025 | marketbeat.comThe Avidity Biosciences, Inc. (NASDAQ:RNA) Second-Quarter Results Are Out And Analysts Have Published New ForecastsAugust 10, 2025 | finance.yahoo.comAvidity (RNA) Q2 Revenue Jumps 88%August 9, 2025 | theglobeandmail.comWells Fargo & Company Issues Positive Forecast for Avidity Biosciences (NASDAQ:RNA) Stock PriceAugust 9, 2025 | marketbeat.comAvidity Biosciences (NASDAQ:RNA) Price Target Raised to $62.00 at BarclaysAugust 9, 2025 | marketbeat.comAvidity Biosciences' (RNA) "Buy" Rating Reaffirmed at Chardan CapitalAugust 9, 2025 | marketbeat.comAvidity Biosciences, Inc. (NASDAQ:RNA) Insider Sells $3,480,489.16 in StockAugust 9, 2025 | insidertrades.comAvidity Biosciences Signs Manufacturing Agreement with LonzaAugust 8, 2025 | theglobeandmail.comAvidity Biosciences price target raised to $75 from $70 at Wells FargoAugust 8, 2025 | msn.comAvidity (RNA) Gets 26% Jump on Potential TakeoverAugust 8, 2025 | msn.comAvidity Biosciences Reports Second Quarter 2025 Financial Results and Recent HighlightsAugust 7, 2025 | prnewswire.comAvidity Biosciences (NASDAQ:RNA) Stock Price Up 18.4% - Time to Buy?August 7, 2025 | marketbeat.comJohn B. Moriarty Sells 2,245 Shares of Avidity Biosciences, Inc. (NASDAQ:RNA) StockAugust 6, 2025 | marketbeat.comNovartis weighs deal for biotech Avidity Biosciences, FT reportsAugust 6, 2025 | reuters.comAvidity Biosciences, Inc. (NASDAQ:RNA) Insider John B. Moriarty Sells 2,245 SharesAugust 6, 2025 | insidertrades.comAssetmark Inc. Grows Position in Avidity Biosciences, Inc. (NASDAQ:RNA)August 2, 2025 | marketbeat.comAvidity Biosciences (RNA) Projected to Post Earnings on FridayAugust 1, 2025 | marketbeat.comWe Think Avidity Biosciences (NASDAQ:RNA) Can Afford To Drive Business GrowthJuly 31, 2025 | finance.yahoo.comTD Asset Management Inc Has $12.79 Million Position in Avidity Biosciences, Inc. (NASDAQ:RNA)July 31, 2025 | marketbeat.comFiera Capital Corp Has $22.80 Million Stake in Avidity Biosciences, Inc. (NASDAQ:RNA)July 30, 2025 | marketbeat.comEnvestnet Asset Management Inc. Has $2.05 Million Position in Avidity Biosciences, Inc. (NASDAQ:RNA)July 30, 2025 | marketbeat.comAvidity Biosciences Announces Completion of Enrollment for HARBOR™, the First Global Phase 3 Trial of Delpacibart Etedesiran (del-desiran) for Treatment of DM1 and Provides Guidance on Regulatory SubmissionJuly 28, 2025 | prnewswire.comUniversal Beteiligungs und Servicegesellschaft mbH Boosts Stock Holdings in Avidity Biosciences, Inc. (NASDAQ:RNA)July 28, 2025 | marketbeat.comNeo Ivy Capital Management Cuts Holdings in Avidity Biosciences, Inc. (NASDAQ:RNA)July 27, 2025 | marketbeat.comAvidity Biosciences (NASDAQ:RNA) Stock Price Up 9.6% - Still a Buy?July 26, 2025 | marketbeat.comAvidity (RNA) Jumps 9.2% on Drug Candidate’s Breakthrough Therapy DesignationJuly 26, 2025 | msn.comAvidity Biosciences stock rises after FDA grants Breakthrough Therapy statusJuly 24, 2025 | investing.comAvidity Biosciences shares climb after FDA grants Breakthrough Therapy designationJuly 24, 2025 | msn.comAvidity Biosciences Receives FDA Breakthrough Therapy Designation for Delpacibart Zotadirsen (del-zota) for the Treatment of DMD in People with Mutations Amenable to Exon 44 SkippingJuly 23, 2025 | prnewswire.com Get Avidity Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for RNA and its competitors with MarketBeat's FREE daily newsletter. Email Address RNA Media Mentions By Week RNA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RNA News Sentiment▼1.000.66▲Average Medical News Sentiment RNA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RNA Articles This Week▼158▲RNA Articles Average Week Get Avidity Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for RNA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Teva Pharmaceutical Industries News Today Summit Therapeutics News Today Genmab A/S News Today Viatris News Today Ascendis Pharma A/S News Today Dr. Reddy's Laboratories News Today QIAGEN News Today Moderna News Today BridgeBio Pharma News Today Verona Pharma PLC American Depositary Share News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:RNA) was last updated on 8/23/2025 by MarketBeat.com Staff From Our PartnersBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avidity Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Avidity Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access